🇺🇸 Interferon-Gamma in United States

395 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 58 reports (14.68%)
  2. Off Label Use — 58 reports (14.68%)
  3. Neutropenia — 54 reports (13.67%)
  4. Pyrexia — 54 reports (13.67%)
  5. Nausea — 35 reports (8.86%)
  6. Respiratory Failure — 31 reports (7.85%)
  7. Pneumonia — 28 reports (7.09%)
  8. Anaemia — 26 reports (6.58%)
  9. Hypotension — 26 reports (6.58%)
  10. Dehydration — 25 reports (6.33%)

Source database →

Interferon-Gamma in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Interferon-Gamma approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Interferon-Gamma in United States?

SPP Pharmaclon Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.